68.10 million. Compared to the same period of last year, it showed a loss of Baht 119.65 million. Signature___________________________ (Mr.Chatchai Pokogwai) Position Managing Director Authorized to sign

Managing Director Authorized to sign on behalf of the company

highly competitive. Consumers are changing their purchasing behavior. Yours Sincerely, Ms. Piyanan Suwannaphasri Assistant Managing Director Authorized to sign behalf of the company

disseminated to many media channels that THG would sign the contract to import mRNA COVID-19 vaccines (Pfizer) and the first 5 million doses of the vaccine would be delivered by July 2021 which does not happen

million (THB 8.4 billion), -7% YoY, Core EBITDA margin 10%  Core Net profit after tax of $128 million (THB 4.0 billion), -27% YoY  Core Earnings Per Share of THB 0.67, -32% YoY  Operating Cash Flow of

of $304 million (THB 9.6 billion), -7% YoY, Core EBITDA margin 10%  Core Net profit after tax of $128 million (THB 4.0 billion), -27% YoY  Core Earnings Per Share of THB 0.67, -32% YoY  Operating

Ventures 2nd Quarter 2018 MD&A 1 Indorama Ventures Public Company Ltd Management Discussion and Analysis 2nd Quarter 2018 Structural Improvements Driving Earnings Momentum  2Q18 Core EBITDA up 63% YoY, 1H18

baht and retained earnings (334.04) million baht. 6. The details of the connected persons and of related persons : -Non- 7. The directors of the board of committee has resolved to accept this due by

2,097.62 1,600.35 Selling & Administrative Expense 127.83 116.99 Finance Costs 24.24 22.96 Net Profit 101.40 (18.95) Earnings per share (Baht) 0.25 (0.047) The company will explain the cause of change as

Revenues 1,711.52 2,072.15 Selling & Administrative Expense 110.78 118.49 Finance Costs 27.51 20.44 Net Profit (12.84) (2.59) Earnings per share (Baht) (0.032) (0.007) The comparison between Third Quarter of